Europe Urinalysis Market, By Testing Type (Urine Biochemistry Testing, Urine Biochemistry Testing), Product (Instruments, Consumables), Test Type (Biochemical, Pregnancy and Fertility, Sediment), Modality (Portable, Standalone, Table Top, Bench Top, Others), Application (Disease Screening, Urinary Tract Infections, Kidney Diseases, Diabetes, Liver Diseases, Pregnancy and Fertility, Others), End User (Hospital, Laboratory, Home Care Settings, Others), Distribution Channel (Direct Tender, Retail Sales) – Industry Trends and Forecast to 2030.
Europe Urinalysis Market Analysis and Size
The new technological advancement is changing and improving the urinalysis testing scenario. The key market players are also taking steps to launch highly automated instruments that use technology to advance diagnosis. As a result, these are driving the urinalysis market. The urinalysis market is being driven by the growing geriatric population in both developed and developing countries. The evolution of new technologies has created numerous opportunities for urinalysis market participants in the forecast period.
Data Bridge Market Research analyses that the urinalysis market which was USD 3.68 billion in 2022, would rocket up to USD 5.52 billion by 2030, and is expected to undergo a CAGR of 5.20% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Europe Urinalysis Market Scope and Segmentation
2023 to 2030
2021 (Customizable to 2015 - 2020)
Revenue in USD Billion, Volumes in Units, Pricing in USD
Testing Type (Urine Biochemistry Testing, Urine Biochemistry Testing), Product (Instruments, Consumables), Modality (Portable, Standalone, Table Top, Bench Top, Others), Application (Urinary Tract Infections, Kidney Diseases, Diabetes, Liver Diseases, Pregnancy & Fertility, Others), End User (Hospital, Laboratory, Home Care Settings, Others), Distribution Channel (Direct Tender, Retail Sales)
Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe
Market Players Covered
Siemens (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health (U.S.), Abbott (U.S.), Danaher (U.S.), Sysmex Corporation (Japan), Quidel Corporation (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), EKF Diagnostics (U.K.), Thermo Fisher Scientific Inc. (U.S.), ARKRAY, Inc. (Japan), ACON Laboratories, Inc. (U.S.), 77 Elektronika Kft. (Hungary), URIT Medical Electronic Group Co., Ltd. (China), Dirui Industrial Co., Ltd. (China), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), BIOBASE Group (China), ERBA Mannheim (U.K.), Alphatech Scientitfic E.I.R.L (Peru), Teco Diagnostics (U.S.), Analyticon Biotechnologies GmbH (Germany)
A urine analysis is a test that is performed to examine the pee. A urine test can be used to help diagnose diseases because the body excretes toxins and extra fluid in the form of urine. Urine analysis can be used to diagnose renal disease and other illnesses. It entails performing a clinical analysis of urine tests to look for specific physical characteristics such as solutes, cells, casts, crystals, organisms, or particle debris.
Europe Urinalysis Market Dynamics
- Increase in age-associated diseases
The ageing population in both developed and developing countries will benefit the urinalysis market. The prevalence of age-related illnesses such as diabetes, liver and kidney disease is expected to rise dramatically as the senior population grows rapidly. Increased prescriptions for tests such as creatinine, albumin, glucose, ketones, and bilirubin have resulted from the diagnosis and treatment of such conditions. This market is expected to benefit because urinalysis is used to perform these tests.
- Rising geriatric population
The growing geriatric population in both developed and developing countries is driving the global urinalysis market. Furthermore, the market is expanding as a result of the adoption of point-of-care diagnostics and the rising prevalence of chronic diseases. Furthermore, the desk-bound lifestyle of working people leads to a general lack of good health among the populace in many areas, fuelling demand for better diagnostics such as urinalysis. As a result, the growing demand for routine health checks is a driving factor in the market's growth.
- Rise in significant investments
The high disease prevalence, large patient population, expanding medical tourism, improving healthcare infrastructure, and rising disposable income in these countries. As European markets mature, the majority of players are shifting their focus to emerging markets. Upgrading laboratory infrastructure in emerging markets is critically dependent on significant investments in healthcare and life sciences research in these countries. As a result, the market for urinalysis expands and encourages the installation of diagnostic equipment in laboratories.
- Unfavourable reimbursement scenario
The availability of refurbished instruments, which perform the same functions as new equipment at a lower cost, poses a threat to the sector's growth. The lack of strong regulatory frameworks may lead to an increase in the economy's consumption of used goods.
This urinalysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the urinalysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Urinalysis Market
With the COVID-19 pandemic, there is a greater need for more accurate and user-friendly testing technologies, as well as the expansion of testing infrastructures, in addition to the development of vaccines and therapeutic medications. As a result of COVID-19, which impacted the regulatory environment and procedures, governments and healthcare providers are facing unprecedented challenges. Regulatory authorities used methods to expedite the approval of diagnostic products. Businesses have made strategic advancements in order to adopt COVID-19 rapid testing, maintain revenues, and mitigate the impact of COVID-19 on their operational capacities.
- In 2020, DIRUI announced the signing of an agreement to build a laboratory for high-quality IVD product manufacturing in collaboration with Changchun Center Hospital. This decision aided in the implications of the testing process, reduced repeated examinations, and reduced the cost of diagnosis. This will result in significant growth for the company over time.
Europe Urinalysis Market Scope
The urinalysis market is segmented on the basis of testing type, product, modality, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Urine Biochemistry Testing
- Urine Biochemistry Testing
- • Instruments
- Biochemical Urine Analyzers
- Automated biochemical analyzers
- Semi-automated Biochemical Analyzers
- Automated Urine Sediment Analyzers
- Microscopic Urine Analyzers
- Flow-Cytometric Urine Analyzers
- Point-Of-Care Urine Analyzers
- • Consumables
- Pregnancy and Fertility Kits
- Table Top
- Bench Top
- Urinary Tract Infections
- Kidney Diseases
- Liver Diseases
- Pregnancy and Fertility
- Home Care Settings
- Direct Tender
- Retail Sales
Urinalysis Market Regional Analysis/Insights
The urinalysis market is analyzed and market size insights and trends are provided by country, testing type, product, modality, application and end-user as referenced above.
The countries covered in the urinalysis market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
Germany is one of the leading countries in the world with rapidly rising diagnosis rate with growing government initiatives for awareness regarding importance of diagnosis.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Urinalysis Market Share Analysis
The urinalysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to urinalysis market.
Some of the major players operating in the urinalysis market are:
- Siemens (Germany)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Cardinal Health (U.S.)
- Abbott (U.S.)
- Danaher (U.S.)
- Sysmex Corporation (Japan)
- Quidel Corporation (U.S.)
- BD (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- EKF Diagnostics (U.K.)
- Thermo Fisher Scientific Inc. (U.S.)
- ARKRAY, Inc. (Japan)
- ACON Laboratories, Inc. (U.S.)
- 77 Elektronika Kft. (Hungary)
- URIT Medical Electronic Group Co., Ltd. (China)
- Dirui Industrial Co., Ltd. (China)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
- BIOBASE Group (China)
- ERBA Mannheim (U.K.)
- Alphatech Scientitfic E.I.R.L (Peru)
- Teco Diagnostics (U.S.)
- Analyticon Biotechnologies GmbH (Germany)